Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese

Long-Term Safety and Efficacy of Topical Cyclosporine in 156 Children with Vernal Keratoconjunctivitis

(2017) N. Pucci et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Application of the Itch Severity Score in patients with moderate-to-severe plaque psoriasis: Clinically important difference and responder analyses

(2014) Carla M. Mamolo et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Itch Severity and Quality of Life in Patients with Pruritus: Preliminary Validity of a Danish Adaptation of the Itch Severity Scale

(2013) R Zachariae et al.   ACTA DERMATO-VENEREOLOGICA

Topical Cyclosporine in the Treatment of Allergic Conjunctivitis

(2013) Kelvin Ho-Nam Wan et al.   OPHTHALMOLOGY

Epidemiology of allergic conjunctivitis

(2011) Nelson Rosario et al.   Current Opinion in Allergy and Clinical Immunology

What have we learnt from ISAAC phase III in the Asia-Pacific rim?

(2009) Annie OL Fok et al.   Current Opinion in Allergy and Clinical Immunology

Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children

(2008) Ugur Keklikci et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY